Vascular Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Vascular Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Vascular Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Vascular Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. Vascular Grafts are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Vascular Grafts Overview
  • Products under Development
    • Vascular Grafts - Pipeline Products by Stage of Development
      • Table Vascular Grafts - Pipeline Products by Stage of Development
      • Table Vascular Grafts - Pipeline Products by Stage of Development
    • Vascular Grafts - Pipeline Products by Segment
      • Table Vascular Grafts - Pipeline Products by Segment
      • Table Vascular Grafts - Pipeline Products by Segment
    • Vascular Grafts - Pipeline Products by Territory
      • Table Vascular Grafts - Pipeline Products by Territory
      • Table Vascular Grafts - Pipeline Products by Territory
    • Vascular Grafts - Pipeline Products by Regulatory Path
      • Table Vascular Grafts - Pipeline Products by Regulatory Path
      • Table Vascular Grafts - Pipeline Products by Regulatory Path
    • Vascular Grafts - Pipeline Products by Estimated Approval Date
      • Table Vascular Grafts - Pipeline Products by Estimated Approval Date
      • Table Vascular Grafts - Pipeline Products by Estimated Approval Date
    • Vascular Grafts - Ongoing Clinical Trials
      • Table Vascular Grafts - Ongoing Clinical Trials
      • Table Vascular Grafts - Ongoing Clinical Trials
  • Vascular Grafts - Pipeline Products under Development by Companies
    • Vascular Grafts Companies - Pipeline Products by Stage of Development
      • Table Vascular Grafts Companies - Pipeline Products by Stage of Development
    • Vascular Grafts - Pipeline Products by Stage of Development
      • Table Vascular Grafts - Pipeline Products by Stage of Development
  • Vascular Grafts Companies and Product Overview
    • 3DT Holdings LLC Company Overview
      • 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table PVP Biological Patch - Product Status
        • Table PVP Biological Patch - Product Description
        • Table Small Peripheral Vessel Graft - Product Status
        • Table Small Peripheral Vessel Graft - Product Description
    • Andes University Company Overview
      • Andes University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Andes University Pipeline Products & Ongoing Clinical Trials Overview
        • Table SiSgraft - Product Status
        • Table SiSgraft - Product Description
    • Angiograft LLC Company Overview
      • Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular Graft - Product Status
        • Table Vascular Graft - Product Description
    • Aquedeon Medical Inc Company Overview
      • Aquedeon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aquedeon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Duett Vascular Graft System - Product Status
        • Table Duett Vascular Graft System - Product Description
        • Table Aquedeon Medical Inc - Ongoing Clinical Trials Overview
        • Table Duett Vascular Graft System - A Pivotal Study of Duett Vascular Graft System
    • Ariste Medical LLC Company Overview
      • Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Eluting Vascular Graft - Product Status
        • Table Drug Eluting Vascular Graft - Product Description
    • Artivion Inc Company Overview
      • Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synergraft Xenograft Vascular Graft - Product Status
        • Table Synergraft Xenograft Vascular Graft - Product Description
    • Aruga Technologies LLC Company Overview
      • Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Topograft - Product Status
        • Table Topograft - Product Description
    • BioDGraft GmbH Company Overview
      • BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Graft - Arteriosclerosis - Product Status
        • Table Biodegradable Graft - Arteriosclerosis - Product Description
    • BioIntegral Surgical Inc Company Overview
      • BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-valved Conduit - Product Status
        • Table Non-valved Conduit - Product Description
    • Biosurfaces Inc Company Overview
      • Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioFunc - APC Vascular Graft - Product Status
        • Table BioFunc - APC Vascular Graft - Product Description
    • Cardiojustable LLC (Inactive) Company Overview
      • Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adjustable SPA Shunt - Product Status
        • Table Adjustable SPA Shunt - Product Description
    • Cardiovate Company Overview
      • Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
        • Table NeoVessel Vascular Graft - Product Status
        • Table NeoVessel Vascular Graft - Product Description
    • Colorado Therapeutics, LLC Company Overview
      • Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xenograft Implant - Peripheral Vascular Disease - Product Status
        • Table Xenograft Implant - Peripheral Vascular Disease - Product Description
    • Cytograft Tissue Engineering Inc (Inactive) Company Overview
      • Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lifeline TEBV - Lower Limb - Product Status
        • Table Lifeline TEBV - Lower Limb - Product Description
        • Table LifeLine TEBV - Pediatric - Product Status
        • Table LifeLine TEBV - Pediatric - Product Description
    • DSM Biomedical BV Company Overview
      • DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Small Diameter Vascular Graft - Product Status
        • Table Small Diameter Vascular Graft - Product Description
    • Eqalix, Inc. Company Overview
      • Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CardioVessel - Product Status
        • Table CardioVessel - Product Description
        • Table LCL Graft - Product Status
        • Table LCL Graft - Product Description
    • FIT Biotech Oy (Inactive) Company Overview
      • FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table GTU X-Graft - Product Status
        • Table GTU X-Graft - Product Description
        • Table GTU X2-Graft - Product Status
        • Table GTU X2-Graft - Product Description
    • Gel-Del Technologies, Inc. Company Overview
      • Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table VasoGraft - Product Status
        • Table VasoGraft - Product Description
    • Hannover Medical School Company Overview
      • Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioartificial Vascular Graft - Product Status
        • Table Bioartificial Vascular Graft - Product Description
    • Humacyte Inc Company Overview
      • Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Humacyl Graft - CABG - Product Status
        • Table Humacyl Graft - CABG - Product Description
        • Table Humacyl Graft - Critical Limb Ischemia - Product Status
        • Table Humacyl Graft - Critical Limb Ischemia - Product Description
        • Table Humacyl Graft - Peripheral Artery Disease - Product Status
        • Table Humacyl Graft - Peripheral Artery Disease - Product Description
        • Table Human Acellular Vessel - Vascular Trauma - Product Status
        • Table Human Acellular Vessel - Vascular Trauma - Product Description
        • Table Humacyte Inc - Ongoing Clinical Trials Overview
        • Table Human Acellular Vessel - Vascular Trauma - A Compassionate Use Study of Humacyte's Human Acellular Vessel for the Treatment of Patients with Critical Limb Ischemia and Vascular Trauma
        • Table Human Acellular Vessel - Vascular Trauma - A Phase 2/3 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma
        • Table Human Acellular Vessel - Vascular Trauma - An Observational Multicenter Study to Evaluate the Safety and Efficacy of Humacyte's Human Acellular Vessel in a Real World Setting for Arterial Replacement or Reconstruction in Ukrainian Patients with Life or Limb-threatening Vascular Trauma
    • Innovia LLC Company Overview
      • Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 4mm Vascular Graft - Product Status
        • Table 4mm Vascular Graft - Product Description
    • Merit Medical Systems Inc Company Overview
      • Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Self-expanding Covered Stent Graft - Product Status
        • Table Self-expanding Covered Stent Graft - Product Description
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coronary Stent Graft System - Product Status
        • Table Coronary Stent Graft System - Product Description
    • Nationwide Children's Hospital Company Overview
      • Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Second-Generation Tissue Engineered Vascular Graft - Product Status
        • Table Second-Generation Tissue Engineered Vascular Graft - Product Description
        • Table Nationwide Children's Hospital - Ongoing Clinical Trials Overview
        • Table Second-Generation Tissue Engineered Vascular Graft - Prospective, Open-labelled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection
    • Northwestern University Company Overview
      • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table ePTFE Graft - Peripheral Arterial Disease - Product Status
        • Table ePTFE Graft - Peripheral Arterial Disease - Product Description
    • Peca Labs Inc Company Overview
      • Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table exGraft II - Product Status
        • Table exGraft II - Product Description
    • PetVivo Holdings Inc Company Overview
      • PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peripheral Vascular Graft - Product Status
        • Table Peripheral Vascular Graft - Product Description
    • PQ Bypass Inc Company Overview
      • PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TORUS Stent Graft System - Product Status
        • Table TORUS Stent Graft System - Product Description
        • Table PQ Bypass Inc - Ongoing Clinical Trials Overview
        • Table TORUS Stent Graft System - The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2
    • RegenaGraft Company Overview
      • RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table RegenaVasc - Product Status
        • Table RegenaVasc - Product Description
    • RUA Vascular Ltd Company Overview
      • RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Elast-Eon - Critical Limb Ischemia - Product Status
        • Table Elast-Eon - Critical Limb Ischemia - Product Description
        • Table Elast-Eon - Peripheral Artery Disease - Product Status
        • Table Elast-Eon - Peripheral Artery Disease - Product Description
        • Table Elast-Eon Large Bore Vascular Graft - Product Status
        • Table Elast-Eon Large Bore Vascular Graft - Product Description
    • Secant Group LLC Company Overview
      • Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Regenerez Graft - Product Status
        • Table Regenerez Graft - Product Description
    • Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview
      • Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TIPS Stent Graft System - Product Status
        • Table TIPS Stent Graft System - Product Description
        • Table Shanghai MicroPort Endovascular MedTech Group Co Ltd - Ongoing Clinical Trials Overview
        • Table TIPS Stent Graft System - A Prospective, Multicenter, Single-group, Target-value Trial to Evaluate the Safety and Efficacy of Tips Coated Stent System in the Treatment of Portal Hypertension
    • Southern University of Science and Technology Company Overview
      • Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artificial Blood Vessel - Product Status
        • Table Artificial Blood Vessel - Product Description
    • Stanford University Company Overview
      • Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table SDF-Eluting Vascular Conduit - Product Status
        • Table SDF-Eluting Vascular Conduit - Product Description
    • STENTiT BV Company Overview
      • STENTiT BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table STENTiT BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Regenerative Stent - Product Status
        • Table Regenerative Stent - Product Description
    • Tgen Tech LLC Company Overview
      • Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table TxGuard - Product Status
        • Table TxGuard - Product Description
    • Transmural systems LLC Company Overview
      • Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Cavopulmonary Bypass Endograft - Product Status
        • Table Transcatheter Cavopulmonary Bypass Endograft - Product Description
    • TTK Healthcare Ltd Company Overview
      • TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chitra Vascular Graft - Product Status
        • Table Chitra Vascular Graft - Product Description
    • University of Louisville Company Overview
      • University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular Graft System - Product Status
        • Table Vascular Graft System - Product Description
    • University of Nebraska Medical Center Company Overview
      • University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiac Vascular Access Graft - Product Status
        • Table Cardiac Vascular Access Graft - Product Description
    • University of Pittsburgh Company Overview
      • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomimetic Vascular Graft - Product Status
        • Table Biomimetic Vascular Graft - Product Description
    • Vascudyne Inc Company Overview
      • Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRUE Graft for Coronary Artery Bypass - Product Status
        • Table TRUE Graft for Coronary Artery Bypass - Product Description
    • VenoStent Inc Company Overview
      • VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SelfWrap - Product Status
        • Table SelfWrap - Product Description
        • Table VenoStent Inc - Ongoing Clinical Trials Overview
        • Table SelfWrap - Feasibility Study to Evaluate the Safety and Efficacy of VenoStent SelfWrap in End-stage Renal Disease Patients
        • Table SelfWrap - SAVE-Fistulas: The SelfWrap-Assisted Arteriovenous Fistulas Study
    • VesselTek BioMedical LLC Company Overview
      • VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table VTek Graft - Product Status
        • Table VTek Graft - Product Description
    • VESSL Therapeutics Ltd Company Overview
      • VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MultiGeneGraft - Product Status
        • Table MultiGeneGraft - Product Description
    • Vygon SA Company Overview
      • Vygon SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vygon SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vygon Vascular Graft - Product Status
        • Table Vygon Vascular Graft - Product Description
    • Xeltis AG Company Overview
      • Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endogenous Tissue Restoration (ETR) Cardiovascular Graft - Product Status
        • Table Endogenous Tissue Restoration (ETR) Cardiovascular Graft - Product Description
    • Yale University Company Overview
      • Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Human iPSC-based Tissue Engineered Vascular Graft - Product Status
        • Table Human iPSC-based Tissue Engineered Vascular Graft - Product Description
  • Vascular Grafts- Recent Developments
    • May 22, 2024: MicroPort Announces Board and Committee Lineup
    • Apr 13, 2024: Atrium Medical Receives Additional FDA 510(k) Clearance for Flixene IFG Vascular Grafts With Assisted Delivery
    • Apr 10, 2024: Atrium Medical Receives FDA 510(k) Clearance for Advanta VXT Vascular Graft
    • Mar 19, 2024: PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
    • Mar 18, 2024: Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System
    • Mar 11, 2024: W. L. Gore & Associates Receives Additional 510(K) Clearance For GORE PROPATEN Vascular Graft
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
    • Feb 09, 2024: Human Acellular Vessel (HAV) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
    • Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
    • Jan 29, 2024: W. L. Gore & Associates Additional 510(K) Clearance For GORE PROPATEN Vascular Graft
    • Jan 29, 2024: Peca Labs Receives Additional FDA 510(k) Clearance for exGraft ePTFE Vascular Graft
    • Jan 29, 2024: Peca Labs Receives Additional 510(K) Clearance For exGraft Carbon ePTFE Vascular Graft
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Dec 20, 2023: RUA Life Sciences : Heart Valve Leaflet Material - Testing Update
    • Dec 12, 2023: Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel (HAV) for the Treatment of Vascular Trauma
    • Nov 20, 2023: RUA Life Sciences Announces Strategy Update
    • Nov 17, 2023: Humacyte Announces Two Presentations at the VEITHsymposium of Positive Clinical Results of the Human Acellular Vessel (HAV) in the Treatment of Vascular Trauma
    • Nov 10, 2023: Microport Appointment of Director
    • Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
    • Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
    • Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
    • Sep 18, 2023: Humacyte to Host In-Person Kol Event at the New York Edition on September 20, 2023
    • Sep 12, 2023: Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel (HAV) in Treatment of Patients with Vascular Trauma
    • Sep 11, 2023: Results From Mayo Clinic Clinical Study of Humacyte's Human Acellular Vessel (HAV) in Treatment of Patients with Chronic Limb Ischemia Presented at Midwestern Vascular Conference
    • Sep 11, 2023: Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel (HAV) Tuesday, September 12, 2023 at 8:00 AM ET
    • Aug 23, 2023: Aquedeon Medical, Receives FDA IDE Approval For The Duett Vascular Graft System
    • Aug 15, 2023: Humacyte Presents Clinical Performance of Human Acellular Vessel (HAV) From Ukrainian Humanitarian Program
    • Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference
    • Aug 03, 2023: Humacyte Announces Publication of Biological Mechanism Explaining Low Rates of Infection Observed in Clinical Study of Human Acellular Vessel (HAV)
    • Jul 26, 2023: Humacyte Completes Enrollment in Phase 2/3 Trial of Human Acellular Vessel (HAV) for Vascular Trauma Repair
    • Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
    • Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings